Can you write a concise SOAP note for an adult (>50 years) with hypertension, cardiovascular disease and on anticoagulants who presents with acute lower gastrointestinal bleeding manifested by fresh red or maroon stool, abdominal cramping and recent NSAID or anticoagulant use?

SOAP Note: Acute Lower Gastrointestinal Bleeding

Subjective

Chief Complaint: Bright red or maroon blood per rectum

History of Present Illness:

• Onset and character of bleeding: Timing of first episode, volume (number of bowel movements with blood, presence of clots), color (bright red suggests distal source, maroon suggests more proximal colon or brisk upper GI source) 1
• Associated symptoms: Abdominal cramping (location, severity), lightheadedness, syncope (predicts severe bleeding), palpitations 1, 2
• Recent medication use: NSAIDs (critical risk factor), anticoagulants (warfarin, DOACs), antiplatelet agents (aspirin, clopidogrel) 1
• Prior episodes: Previous lower GI bleeding admissions (component of Oakland score) 1
• Upper GI symptoms: Hematemesis, coffee-ground emesis, or melena (10-15% of severe hematochezia originates from upper GI tract) 3, 2

Past Medical History:

• Cardiovascular disease (affects transfusion thresholds and antiplatelet management) 1, 3
• Hypertension (affects transfusion targets) 3, 2
• Atrial fibrillation or mechanical heart valves (determines thrombotic risk for anticoagulation resumption) 1
• Prior peptic ulcer disease or portal hypertension (increases likelihood of upper GI source) 3, 2
• Diverticulosis, inflammatory bowel disease, prior colorectal polyps 1, 4

Medications:

• Anticoagulants: Warfarin (requires PCC + vitamin K for reversal), DOACs (idarucizumab for dabigatran, andexanet for factor Xa inhibitors) 1, 3
• Antiplatelet agents: Aspirin (primary vs. secondary prevention determines management), P2Y12 inhibitors 1
• NSAIDs (must be permanently discontinued) 1

Objective

Vital Signs:

• Calculate shock index immediately: Heart rate ÷ systolic blood pressure; >1 = hemodynamically unstable 1, 3, 2
• Blood pressure (systolic <100 mmHg or orthostatic hypotension predicts severe bleeding) 2
• Heart rate (>100 bpm predicts severe bleeding) 2

Physical Examination:

• General appearance: Pallor, diaphoresis, altered mental status 1
• Digital rectal examination (mandatory): Presence of gross blood (independent predictor of severe bleeding), color of stool, exclude anorectal pathology (accounts for 16.7% of diagnoses) 1, 2, 4
• Abdominal examination: Tenderness, guarding, rigidity (peritoneal signs mandate immediate surgical consultation) 3

Laboratory Studies:

• Complete blood count: Hemoglobin (component of Oakland score; <70 g/L = 22 points), hematocrit (decrease ≥6% indicates ICU admission) 1, 2
• Coagulation profile: INR (>1.5 requires correction with PCC + vitamin K), PT 1
• Platelet count: <50×10⁹/L requires platelet transfusion 1, 2
• Type and cross-match: Prepare for transfusion 2
• BUN/creatinine ratio: >30 suggests upper GI source 2

Risk Stratification:

• Oakland Score (for stable patients, shock index ≤1): Age, gender, previous LGIB admission, DRE findings, heart rate, systolic BP, hemoglobin 1, 2
  • ≤8 points: Safe for discharge with outpatient colonoscopy within 2 weeks (6% have colorectal cancer) 1, 2
  • >8 points: Admit for inpatient colonoscopy on next available list 1, 2

Assessment

Primary Diagnosis: Acute lower gastrointestinal bleeding

Severity Classification:

• Hemodynamically unstable (shock index >1): Requires immediate CT angiography, NOT colonoscopy 1, 3, 2
• Hemodynamically stable, major bleed (Oakland score >8): Requires hospital admission 1
• Hemodynamically stable, minor bleed (Oakland score ≤8): Safe for outpatient management 1

Differential Diagnosis by Age and Risk Factors:

• Age >60 years: Diverticulosis (21-41% of cases, most common cause), angiodysplasia (3-40%) 4, 5
• Anticoagulant use: Increases severe bleeding rate (55.1% vs. 35.4%) and worsens outcomes 3
• Anorectal conditions: Hemorrhoids, fissures (16.7% of diagnoses) 4
• Colorectal malignancy/polyps: 6-27% of cases, typically chronic intermittent bleeding 4
• Upper GI source: 10-15% of severe hematochezia, especially with hemodynamic instability 3, 2

Mortality Risk:

• Overall in-hospital mortality: 3.4% 3, 2
• Inpatient-onset bleeding: 18% mortality 3
• Requiring ≥4 units RBCs: 20% mortality 3, 2

Plan

Immediate Management (All Patients)

1. Hemodynamic Resuscitation:

• Two large-bore IV catheters with aggressive crystalloid infusion (normal saline or Ringer's lactate) 2
• Restrictive transfusion strategy 3, 2:
  • No cardiovascular disease: Transfuse at Hb ≤70 g/L, target 70-90 g/L 3, 2
  • Cardiovascular disease/hypertension: Transfuse at Hb ≤80 g/L, target ≥100 g/L 3, 2
• Correct coagulopathy immediately 1, 2:
  • INR >1.5: Fresh frozen plasma 1, 2
  • Platelets <50×10⁹/L: Platelet transfusion 1, 2

2. Anticoagulation Management:

Warfarin 1, 3:

• Interrupt immediately at presentation 1, 3
• Unstable hemorrhage: Reverse with 4-factor prothrombin complex concentrate (PCC) + low-dose vitamin K (<5 mg) 1, 3
• Do NOT use fresh frozen plasma as first-line (slower, requires ABO matching, volume overload risk) 1, 3
• Resumption timing 1:
  • Low thrombotic risk: Restart at 7 days after hemostasis 1
  • High thrombotic risk (mechanical mitral valve, recent VTE <3 months): Consider bridging with LMWH at 48 hours, restart warfarin at 3 days 1, 3

Direct Oral Anticoagulants (DOACs) 1, 3:

• Interrupt immediately at presentation 1, 3
• Life-threatening hemorrhage: Consider reversal agents 1, 3:
  • Dabigatran: Idarucizumab 1, 3
  • Factor Xa inhibitors (rivaroxaban, apixaban): Andexanet alfa 1, 3
• Resumption: Maximum 7 days after hemostasis 3

3. Antiplatelet Management:

Aspirin 1, 6:

• Primary prevention: Permanently discontinue 1
• Secondary prevention: Do NOT routinely stop; if stopped, restart as soon as hemostasis achieved (same day endoscopically confirmed) 1, 6

Dual Antiplatelet Therapy (DAPT) 1:

• Continue aspirin 1
• P2Y12 inhibitor: Restart within 5 days if interrupted 1
• Manage in liaison with cardiology for patients with coronary stents 3

Diagnostic Algorithm

HEMODYNAMICALLY UNSTABLE (Shock Index >1):

Step 1: CT Angiography (CTA) FIRST 1, 3, 2:

• Sensitivity 94%, detects bleeding ≥0.3 mL/min 3, 2
• Fastest, least invasive localization method 3, 2
• Colonoscopy is CONTRAINDICATED (requires 4-6L PEG prep over 3-4 hours, sedation worsens shock) 1, 3, 2

Step 2: If CTA Positive 3, 2:

• Catheter angiography with embolization within 60 minutes 3, 2
• Achieves hemostasis in 40-100% of cases 3, 2

Step 3: If CTA Negative for Lower GI Source 3, 2:

• Upper endoscopy immediately (10-15% of severe hematochezia is upper GI) 3, 2

Step 4: Surgery (Last Resort Only) 3, 2:

• Reserved for failure of angiographic intervention OR continued deterioration despite all localization attempts 3, 2
• Peritoneal signs (guarding, rigidity): Immediate surgical consultation for possible bowel catastrophe 3
• Blind segmental resection: 33% rebleeding rate, 33-57% mortality 3, 2

---

HEMODYNAMICALLY STABLE (Shock Index ≤1):

Step 1: Digital Rectal Examination 1, 2:

• Confirm blood, exclude anorectal pathology (16.7% of diagnoses) 1, 4

Step 2: Calculate Oakland Score 1, 2:

Oakland Score ≤8 Points 1, 2:

• Discharge for urgent outpatient colonoscopy within 2 weeks 1, 2
• 6% have underlying colorectal cancer 1

Oakland Score >8 Points 1, 2:

• Admit for inpatient colonoscopy on next available list (NOT urgently within 24 hours) 1, 2
• Urgent colonoscopy does NOT improve rebleeding, mortality, or length of stay 1, 2

Step 3: Colonoscopy After Adequate Bowel Preparation 1, 2:

• 4-6L polyethylene glycol over 3-4 hours 2
• Diagnostic yield 42-90% 2
• Therapeutic interventions: Clipping, thermal coagulation, injection therapy 1, 5

Step 4: If Colonoscopy Nondiagnostic and Bleeding Persists 2:

• Catheter angiography for localization and embolization 2

ICU Admission Criteria 3, 2

Admit to ICU if ANY of the following:

• Orthostatic hypotension 3, 2
• Hematocrit decrease ≥6% 3, 2
• Transfusion requirement >2 units 3, 2
• Continuous active bleeding 3, 2
• Persistent hemodynamic instability despite resuscitation 3, 2

Common Pitfalls to Avoid

• Do NOT rush to colonoscopy in unstable patients (shock index >1)—this delays definitive CTA localization and potential embolization 1, 3, 2
• Do NOT assume bright red blood is always lower GI—up to 15% may be upper GI source 3, 2
• Do NOT perform colonoscopy without adequate bowel preparation—leads to missed lesions and repeat procedures 1, 2
• Do NOT proceed to surgery without prior localization (CTA/angiography)—blind resection has 33% rebleeding and 33-57% mortality 3, 2
• Do NOT use fresh frozen plasma as first-line warfarin reversal—use PCC + vitamin K 1, 3
• Do NOT stop aspirin for secondary cardiovascular prevention—myocardial infarction risk outweighs bleeding risk 1, 6

Disposition and Follow-Up

Oakland Score ≤8 (Stable, Minor Bleed):

• Discharge with outpatient colonoscopy within 2 weeks 1, 2
• Permanently discontinue NSAIDs 1
• Adjust anticoagulation/antiplatelet therapy per above algorithm 1

Oakland Score >8 (Stable, Major Bleed):

• Admit for inpatient colonoscopy on next available list 1, 2
• Continue hemodynamic monitoring 2

Shock Index >1 (Unstable):

• ICU admission 3, 2
• Immediate CTA → angiography/embolization pathway 3, 2
• Surgical consultation if peritoneal signs or failure of endovascular therapy 3